Skip to main content

UBS Group AG

SEC CIK
0001610520
Latest filing
Aug 13, 2026

ACET holding history

Adicet Bio, Inc. in every 13F filed by UBS Group AG, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

ACET overviewAll 13F holders of ACETFull Q2 2026 holdings

Shares (Q2 2026)
29,817
Value
$257.6K
% of portfolio
<0.1%
Quarters held
19
Since Q1 2021
Holdings of ACET by UBS Group AG, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202629,817$257.6K<0.1%−8,551−22.3%ReducedHolders
Q1 202638,368$261.3K<0.1%+34,571+910.5%AddedHolders
Q4 20253,797$32.0K<0.1%−17,641−82.3%ReducedHolders
Q3 202521,438$17.4K<0.1%+2,930+15.8%AddedHolders
Q2 202518,508$11.3K<0.1%−45,531−71.1%ReducedHolders
Q1 202564,039$48.3K<0.1%−139,190−68.5%ReducedHolders
Q4 2024203,229$195.5K<0.1%+161,625+388.5%AddedHolders
Q3 202441,604$59.9K<0.1%−119,231−74.1%ReducedHolders
Q2 2024160,835$194.6K<0.1%+107,297+200.4%AddedHolders
Q1 202453,538$125.8K<0.1%+30,960+137.1%AddedHolders
Q4 202322,578$42.7K<0.1%+18,241+420.6%AddedHolders
Q3 20234,337$5.94K<0.1%+4,310+15,963.0%AddedHolders
Q2 202327$66<0.1%+27NewHolders
Q1 20230$00.0%−117,589−100.0%Sold outHolders
Q4 2022117,589$1.05M<0.1%+100,320+580.9%AddedHolders
Q3 202217,269$246.0K<0.1%+17,269NewHolders
Q2 20220$00.0%−547−100.0%Sold outHolders
Q1 2022547$11.0K<0.1%−9,338−94.5%ReducedHolders
Q4 20219,885$173.0K<0.1%+9,733+6,403.3%AddedHolders
Q3 2021152$1.00K<0.1%+152NewHolders
Q2 20210$00.0%−1,693−100.0%Sold outHolders
Q1 20211,693$22.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.